Strategic focus Forepont Capital Partners specializes in Medtech, biotech and digital health startups across the US and Europe, presenting a clear target for partnerships, collaboration opportunities, and potential co-investment or portfolio synergies with healthcare technology vendors and research institutions.

Recent wins Active deal activity includes a $41M Series B investment in Precision Neuroscience and a €6M Series A for Basecamp Vascular, signaling ongoing fundraising momentum and potential for follow-on investments, strategic introductions, and leveraging portfolio successes to attract co-investors.

Global reach Headquartered in New York with a European presence, Forepont offers access to cross‑border funding and market-entry support, creating opportunities for vendors, CROs, and service providers seeking multi-region expansion and regulatory navigation expertise.

Portfolio engagement The firm emphasizes scientific, technological, financial, and operational support through tight partnerships with researchers, hospitals, academia, and larger pharma groups, offering potential collaboration channels for service providers, data analytics firms, and clinical partnership opportunities.

Financial health With revenue in the mid range of 10 to 25 million and a lean team, Forepont could be prioritizing high-value, high-margin deals and value-add services; sales opportunities exist in strategic consulting, regulatory affairs, data analytics, and digital health solutions tailored to growth-stage biotech and medtech companies.